Dec 10, 2019 / 04:00PM GMT
Peter J. Kuipers - Omnicell, Inc. - Executive VP & CFO
Good morning, everyone. Welcome to the Omnicell Investor and Analyst Day at the ASHP mid-year with you. It's good to see everyone in the room. So welcome to the
(technical difficulty)
this morning will include forward-looking statements
(technical difficulty)
this meeting is also webcast live. We will post a recording of today's webcast and a copy of the presentation in the Investor Relation section of our website at omnicell.com.
Let's now move to our agenda. Agenda for today is as follows: first, Randall Lipps, Omnicell's Chairmen, President, CEO and Founder, will give an update on our mission and discuss our purpose, strategy and priorities; next, Scott Seidelmann, Omnicell's Chief Commercial Officer, will discuss interface and medication management and the 3 areas of growth, starting with point-of-care and opportunities we're seeing in central pharmacy. It's how our customers drive better outcomes, fee automation, analytics and services. This is followed by a note for you, of the Autonomous
Omnicell Inc Investor and Analyst Day at the Annual ASHP Midyear Meeting Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot